2m 2m 2m 2m 2m 2m 2m
Inhibitor Therpt (INTI)
OTC
$0.10+$0.01 (+15.47%)
Price as of Sep 11, 2026- $14.1MMarket Cap
- 132.72%1-Year Change
- BiotechnologyIndustry
Inhibitor Therpt (INTI)
$0.10+$0.01 (+15.47%)
INTI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.10 | ||
Change | +$0.01 (+15.47%) | ||
Open | $0.06 | ||
High | $0.10 | ||
Low | $0.06 | ||
Previous Close | $0.09 | ||
Volume | 800 | ||
30-Day Average Volume | 926 | ||
1-Week Change | 35.04% | ||
1-Month Change | 22.46% | ||
1-Year Change | 132.72% | ||
3-Year Change | 98.02% | ||
5-Year Change | -98.88% | ||
Fundamentals | |||
Shares Outstanding | 172.6M | ||
Total Assets | $637,190.00 | ||
Market Cap | $14.1M | ||
Enterprise Value | $13.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$775,220.00 | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $411,912.00 | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | -6 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -18 | ||
Price/Operating Cash Flow | -18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||